71 Pa. Stat. § 1691.3

Current through Pa Acts 2024-53, 2024-56 through 2024-92
Section 1691.3 - Establishment of medication death and incident review team
(a)Team established.--The department shall establish a Medication Death and Incident Review Team and conduct a review and shall examine the circumstances surrounding medication-related deaths and medication-related incidents in this Commonwealth for the purpose of promoting safety, reducing medication-related deaths and medication-related incidents and improving treatment practices.
(b) Composition.--The team shall consist of the following individuals:
(1) The secretary or a designee, who shall serve as the chairperson of the team.
(2) The Director of the Bureau of Drug and Alcohol Programs.
(3) The following individuals appointed by the secretary:
(i) A representative from an opioid-assisted treatment program.
(ii) A representative from a licensed drug and alcohol addiction treatment program that is not defined as an opioid-assisted treatment program.
(iii) A representative from law enforcement recommended by a Statewide association representing members of law enforcement.
(iv) A representative from the medical community recommended by a Statewide association representing physicians.
(v) A district attorney recommended by a Statewide association representing district attorneys.
(vi) A coroner or medical examiner recommended by a Statewide association representing county coroners and medical examiners.
(vii) A member of the public.
(viii) A patient or family advocate.
(ix) A representative from a recovery organization.
(x) An office-based agonist treatment provider who is assigned a waiver from the Drug Enforcement Administration, including a special identification number, commonly referred to as the "X" DEA number, to provide office-based prescribing of buprenorphine.
(xi) A representative of the Department of Health who is affiliated with the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) established under the act of October 27, 2014 ( P.L. 2911, No.191) , known as the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act.
(xii) A toxicologist.
(c) Initial meeting.--The initial meeting of the team shall take place within 90 days of the effective date of this section. During this initial meeting, the team shall develop a schedule for its work and reports.
(d)Expenses.--Members of the team shall not receive compensation but shall be reimbursed for necessary travel and other reasonable expenses incurred in connection with the performance of their duties as members. If possible, the team shall utilize the services and expertise of existing personnel and staff of State government.

71 P.S. § 1691.3

Amended by P.L. TBD 2020 No. 126, § 1, eff. 2/23/2021.
Added by P.L. 1198 2012 No. 148, § 3, eff. 1/22/2013.